InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Dyne Therapeutics, Inc.

DYN Clue Score43
United States Fiscal year ends December CIK 0001818794 Results filed 5 Nov 2026
Add to watchlist

What the insiders did Net buying

Individual transactions

12
Insider
Date
Role
Action
Shares
Price
Amount
Erick Lucera
25 Jun 2026
Chief Financial Officer
Sell
2,362
$20.37
$48.11K
Dirk Kersten
9 Dec 2024
Director
Sell indirect
34,437
$29.18
$1.00M
Dirk Kersten
6 Dec 2024
Director
Sell indirect
101,675
$29.34
$2.98M
Dirk Kersten
5 Dec 2024
Director
Sell indirect
3,806
$29.05
$110.56K
Dirk Kersten
4 Dec 2024
Director
Sell indirect
135,039
$29.39
$3.97M
Dirk Kersten
3 Dec 2024
Director
Sell indirect
29,732
$29.05
$863.71K
Dirk Kersten
2 Dec 2024
Director
Sell indirect
1,228
$30.37
$37.29K
Dirk Kersten
2 Dec 2024
Director
Sell indirect
79,973
$29.66
$2.37M
Jason P Rhodes
14 Nov 2024
Director
Sell indirect
72
$33.10
$2.38K
Jason P Rhodes
14 Nov 2024
Director
Sell indirect
123
$33.10
$4.07K
Jason P Rhodes
14 Nov 2024
Director
Sell indirect
4
$33.10
$132.40
Jason P Rhodes
14 Nov 2024
Director
Sell indirect
583
$33.10
$19.30K
Showing 250 of 478 transactions. The figures above use every one of them.

What was left out

Form 4 filings counted 329
Amendments (4/A) skipped 2
Filings about a different issuer 0
Unreadable filings 0
Joint filings 9
Sales on a Rule 10b5-1 plan 327
Sales straight out of an exercise 62
Sales at will 64
Transactions with no price 0
Shares from compensation/vesting 51,576,564
Sales filed before the plan box existed 30
History held since 18 Sep 2020